Fate Therapeutics, Inc. earnings per share and revenue

FATE earnings per share for the last quarter are -0.33 USD whereas the estimation was -0.46 USD which accounts for 28.81% surprise. Company revenue for the same period amounts to 6.77 M USD despite the estimated figure of 1.33 M USD. Estimated earnings per share for the next quarter are -0.42 USD, and revenue is expected to reach 1.24 M USD. Also watch annual changes over time to get a bigger picture of FATE earnings per share and revenue dynamics.